May 26, 2026 Log in

Dividend Announcement

4164 CHENG UEI: Dividend Resolution for Key Subsidiary Xingye Biotech

Citation-Grade Primary-source linked Schema.org verified NQ 46 / 100

Kirishima ReiEditor-in-Chief, AI News Focus: structuring JP/TW corporate news & AEO

Published May 26, 2026 6:31 AM ・ Updated Jun 14, 2026 12:07 AM ・ 2 min read ・ Source: PR Times

Show contents

⚡ Key Points

CHENG UEI announced that its key subsidiary, Xingye Biotech, has resolved to distribute cash dividends.

CHENG UEI announced that its key subsidiary, Xingye Biotech, has resolved to distribute cash dividends.

PRIMARY SOURCE Original source: https://openapi.twse.com.tw/v1/opendata/t187ap04_L#4164-1150526-54a6f79f Distributor: PR Times
Published: May 26, 2026

On May 25, 2026, CHENG UEI (4164) announced that its key subsidiary, Xingye Biotech Co., Ltd., held a board meeting and resolved to distribute cash dividends. The total amount of the cash dividend is 41,827,852 TWD. There are no other matters to be noted.

FACT BOX

Source: PR Times
Category: Dividend Announcement

Editorial & Verification Standards

The Washin AI News desk structures and reviews this article under the following standards.

Start only from primary sources (official PR, disclosures, wire services)
Numbers and proper nouns machine-checked against the source (number-completeness check)
Company names and tickers verified via registry (Registry/TWSE/Wikidata)
No speculation; nothing stated that is not in the source

Read the full editorial policy →

Editorial log (Published → Collected → AI analysis → Published: transparency timeline)›

Announced　May 26, 2026 6:31 AM — Distributor PR Times
Collected　May 26, 2026 6:31 AM
AI structured & analyzed　May 31, 2026 8:16 PM
Desk-reviewed & published　May 26, 2026 6:31 AM

FAQ

What is CHENG UEI's main business?

Medical equipment sales and maintenance.

What are the key facts in this article?

CHENG UEI announced that its key subsidiary, Xingye Biotech, has resolved to distribute cash dividends.

Where is the primary source?

PR Times: https://openapi.twse.com.tw/v1/opendata/t187ap04_L#4164-1150526-54a6f79f

Cite this article — HOW TO CITE

Washin AI News Desk“4164 CHENG UEI: Dividend Resolution for Key Subsidiary Xingye Biotech”AI News by Washin Village（和心村）, May 26, 2026. https://aeo.idaeo.ai/ai/openapi-twse-com-tw/en/news/2026-05-25-4164-%E6%89%BF%E6%A5%AD%E9%86%AB-3

AI CRAWLER ACTIVITY

as of Aug 16, 2026

AI crawler visits to this article (cumulative)92 bots

Site-wide cumulative

Applebot

bot_visits_summary

3065k

last Aug 16, 2026

GPTBot

bot_visits_summary

2140k

last Aug 16, 2026

Bingbot

bot_visits_summary

812k

last Aug 16, 2026

Amazonbot

bot_visits_summary

584k

last Aug 16, 2026

Meta AI

bot_visits_summary

544k

last Aug 16, 2026

ClaudeBot

bot_visits_summary

411k

last Aug 16, 2026

※ Only measured values from bot_visits_summary / crawler_url_hits are shown. Article-level zero counts are shown as measuring.

Washin AI News（AI News by Washin Village（和心村））

An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.

Daily
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification

About the publisher IDA llms.txt

Get your announcement indexed as AI-citable structured news.
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →

← openapi-twse-com-tw Back to newsroom (21544)

Copied